Sources | Names Used |
---|---|
CTRPv2 | navitoclax:sorafenib (1:1 mol/mol) |
PharmacoGx | navitoclax:sorafenib (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | INO80D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | LRRK1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | AUH | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TSSK6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RPL39L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | GADL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | IFRD2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZNF786 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | USF2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | THOC7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |